Suggestions
Delphine Guyon-Gellin
Chief Business Development Officer chez Osivax
Professional Background
Delphine Guyon-Gellin is a distinguished professional whose multifaceted career spans significant roles in both the veterinary and business sectors. Currently, she serves as the Chief Business Development Officer at Osivax, where she leverages her extensive background in marketing, consulting, and veterinary medicine to drive innovative business strategies and expand the company's presence in the biopharmaceutical field. With a dynamic approach to business development, Delphine focuses on fostering partnerships and exploring new markets, ensuring that Osivax remains at the forefront of vaccine technology.
Prior to her current role, Delphine made her mark in the consulting industry, first as a Consultant at AEC Partners, where she honed her strategic thinking and analytical skills. She then advanced to The Boston Consulting Group (BCG), where she flourished in the fast-paced environment of project management as both a Senior Consultant and Project Leader. Her tenure at BCG equipped her with a wealth of experience in advising clients across various industries on growth strategies, operational efficiency, and market entry, enhancing her business acumen and leadership skills.
Education and Achievements
Delphine holds a Master’s degree in Marketing from HEC Paris, one of the top business schools in Europe, which reflects her strong foundation in the principles of marketing and business strategy. This academic background has been instrumental in shaping her career trajectory, allowing her to blend her technical expertise with strategic insights.
In addition to her Master’s in Marketing, Delphine also earned a Doctor of Veterinary Medicine from the prestigious Ecole nationale vétérinaire d'Alfort. Her veterinary education underscores her commitment to the health and well-being of animals, bringing a unique perspective to her work in the biopharmaceutical industry. By combining her veterinary knowledge with her business skills, Delphine exemplifies how diverse educational backgrounds can lead to innovative leadership in sectors that intertwine healthcare and business.
Delphine’s diverse educational and career experiences not only highlight her capabilities as a leader but also illustrate her adaptability in various challenging environments. Her ability to pivot between different fields has enabled her to cultivate a wide-ranging expertise that positions her as a valuable asset in any organization she is a part of.
Achievements
Delphine Guyon-Gellin's career is marked by several notable achievements that reflect her drive for excellence and passion for innovation. As Chief Business Development Officer at Osivax, she has played an instrumental role in advancing the company's mission to develop cutting-edge vaccines aimed at addressing global health challenges. Her leadership in business development is characterized by the successful implementation of strategic partnerships and initiatives that have significantly enhanced Osivax's market position.
During her time at The Boston Consulting Group, Delphine was recognized for her outstanding contributions to numerous high-stakes projects, advising Fortune 500 companies on critical business transformations. Her analytical prowess and ability to distill complex information into actionable insights have earned her accolades from peers and clients alike.
Delphine's unique combination of veterinary medicine and business expertise not only makes her a trailblazer in her field but also positions her as a thought leader and mentor for aspiring professionals looking to bridge these two domains. Her dedication to fostering a collaborative and innovative environment within her team continues to inspire those around her to push the boundaries of what is possible in the intersection of medicine and business.
